AMGN

$280.33

▲+2.37%

wb_incandescent Backtest

Stock

Amgen Inc. Common Stock

Official Company Name: Amgen Inc.

Stock Symbol: AMGN

Stock Market: NASDAQ Global Select - NASDAQ

Currency: United States dollar - USD

business Amgen Company Profile

AMGN Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+19.42%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Amgen Inc. is a multinational biotechnology and pharmaceutical company. It produces various drugs, including Neulasta, which prevents infections for patients undergoing cancer chemotherapy, Enbrel, a necrosis blocker for the treatment of autoimmune diseases. Focusing on molecular biology and biochemistry, Amgen aims at developing health care through recombinant DNA technology.

business Amgen Company Profile

AMGN Stock Data

Open $276.50
High $281.93
Low $274.88
Close $280.33
Volume 3,772,700
Previous Close $273.83
1-Day Change 6.50
1-Year Change 45.59
Average Daily Volume 2,556,437
52-Week High $324.56
52-Week Low $214.27

AMGN Stock References

warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.